{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:32:28Z","timestamp":1789842748355,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"DOI":"10.7759\/cureus.77763","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T12:19:33Z","timestamp":1737461973000},"source":"Crossref","is-referenced-by-count":2,"title":["Hydroxychloroquine-Induced Cardiomyopathy: A Case Report"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Salih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tebyan","family":"Mohammedali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousif","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Maximilian","family":"Buja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.81.2.221","article-title":"Chloroquine cardiomyopathy with conduction disorders","volume":"81","author":"Baguet JP","year":"1999","unstructured":"Baguet JP, Tremel F, Fabre M. Chloroquine cardiomyopathy with conduction disorders. Heart. 1999, 81:221-3. 10.1136\/hrt.81.2.221","journal-title":"Heart"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04495-w","article-title":"PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS\/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer","volume":"13","author":"Salvi A","year":"2022","unstructured":"Salvi A, Young AN, Huntsman AC, et al.. PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS\/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer. Cell Death Dis. 2022, 13:45. 10.1038\/s41419-021-04495-w","journal-title":"Cell Death Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/s0066-782x2002001000009","article-title":"Cardiac damage from chronic use of chloroquine: a case report and review of the literature","volume":"79","author":"Teixeira RA","year":"2002","unstructured":"Teixeira RA, Martinelli Filho M, Benvenuti LA, Costa R, Pedrosa AA, Nishi\u00f3ka SA. Cardiac damage from chronic use of chloroquine: a case report and review of the literature. Arq Bras Cardiol. 2002, 79:85-8. 10.1590\/s0066-782x2002001000009","journal-title":"Arq Bras Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/08923973.2013.780078","article-title":"Chloroquine cardiomyopathy - a review of the literature","volume":"35","author":"T\u00f6nnesmann E","year":"2013","unstructured":"T\u00f6nnesmann E, Kandolf R, Lewalter T. Chloroquine cardiomyopathy - a review of the literature. Immunopharmacol Immunotoxicol. 2013, 35:434-42. 10.3109\/08923973.2013.780078","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1977.tb16857.x","article-title":"Cardiomyopathy after chloroquine treatment","volume":"202","author":"Magnussen I","year":"1977","unstructured":"Magnussen I, de Fine Olivarius B. Cardiomyopathy after chloroquine treatment. Acta Med Scand. 1977, 202:429-31. 10.1111\/j.0954-6820.1977.tb16857.x","journal-title":"Acta Med Scand"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2021.03.003","article-title":"Unmasking hydroxychloroquine cardiotoxicity in a patient with heart failure and chronotropic incompetence","volume":"3","author":"Ezzeddine FM","year":"2021","unstructured":"Ezzeddine FM, Giudicessi JR, Maleszewski JJ, Lin PT, Borlaug BA, Geske JB. Unmasking hydroxychloroquine cardiotoxicity in a patient with heart failure and chronotropic incompetence. JACC Case Rep. 2021, 3:997-1001. 10.1016\/j.jaccas.2021.03.003","journal-title":"JACC Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.12.66","article-title":"Hydroxychloroquine-induced cardiomyopathy and heart failure in twins","volume":"10","author":"Zhao H","year":"2018","unstructured":"Zhao H, Wald J, Palmer M, Han Y. Hydroxychloroquine-induced cardiomyopathy and heart failure in twins. J Thorac Dis. 2018, 10:70-3. 10.21037\/jtd.2017.12.66","journal-title":"J Thorac Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12276","article-title":"Chloroquine-induced cardiomyopathy: a reversible cause of heart failure","volume":"5","author":"Yogasundaram H","year":"2018","unstructured":"Yogasundaram H, Hung W, Paterson ID, Sergi C, Oudit GY. Chloroquine-induced cardiomyopathy: a reversible cause of heart failure. ESC Heart Fail. 2018, 5:372-5. 10.1002\/ehf2.12276","journal-title":"ESC Heart Fail"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/2048872612471215","article-title":"Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review","volume":"2","author":"Joyce E","year":"2013","unstructured":"Joyce E, Fabre A, Mahon N. Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review. Eur Heart J Acute Cardiovasc Care. 2013, 2:77-83. 10.1177\/2048872612471215","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.3997","article-title":"MRI of cardiomyopathy","volume":"191","author":"Belloni E","year":"2008","unstructured":"Belloni E, De Cobelli F, Esposito A, Mellone R, Perseghin G, Canu T, Del Maschio A. MRI of cardiomyopathy. AJR Am J Roentgenol. 2008, 191:1702-10. 10.2214\/AJR.07.3997","journal-title":"AJR Am J Roentgenol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2004.09.029","article-title":"Chloroquine-induced cardiomyopathy-echocardiographic features","volume":"18","author":"Naqvi TZ","year":"2005","unstructured":"Naqvi TZ, Luthringer D, Marchevsky A, Saouf R, Gul K, Buchbinder NA. Chloroquine-induced cardiomyopathy-echocardiographic features. J Am Soc Echocardiogr. 2005, 18:383-7. 10.1016\/j.echo.2004.09.029","journal-title":"J Am Soc Echocardiogr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick RJ","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J, et al.. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003, 138:338-46. 10.7326\/0003-4819-138-4-200302180-00014","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo M","year":"2020","unstructured":"Jo M, Lee S, Jeon YM, Kim S, Kwon Y, Kim HJ. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp Mol Med. 2020, 52:1652-62. 10.1038\/s12276-020-00513-7","journal-title":"Exp Mol Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67612","article-title":"A rare case of Fabry\u2019s disease-induced cardiomyopathy: a case report and review of the literature","volume":"16","author":"Hussein A","year":"2024","unstructured":"Hussein A, Salih A, Mohamed Y, Thames E, Buja LM. A rare case of Fabry\u2019s disease-induced cardiomyopathy: a case report and review of the literature. Cureus. 2024, 16:67612. 10.7759\/cureus.67612","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jez319.517","article-title":"P873 a rare and potentially treatable cause of left ventricular hypertrophy","volume":"21","author":"Wong CY","year":"2020","unstructured":"Wong CY. P873 a rare and potentially treatable cause of left ventricular hypertrophy. Eur Heart J Cardiovasc Imaging. 2020, 21:10.1093\/ehjci\/jez319.517","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/330434-hydroxychloroquine-induced-cardiomyopathy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T12:19:36Z","timestamp":1737461976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/330434-hydroxychloroquine-induced-cardiomyopathy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.77763","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,21]]}}}